Condition
Familial Hypercholesterolemia - Heterozygous clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Familial Hypercholesterolemia - Heterozygous clinical trials that are recruiting, at sites in 23 countries (most in Spain (2), Argentina (1), Austria (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 23Countries
All recruiting trials (2)
-
Evaluating Inclisiran for Children with Familial Hypercholesterolemia
This study is testing if a new medication called inclisiran can safely lower cholesterol levels in children aged 6 to under 12 who have a genetic condition that causes high cholesterol.
-
Detecting Familial Hypercholesterolemia in Children
This study is trying to find out if we can identify children with a genetic condition that causes high cholesterol so they can get early treatment and avoid heart problems later in life.
Related topics
Quick answers
How many Familial Hypercholesterolemia - Heterozygous clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 23 countries. The most sites are in Spain (2 trials), Argentina (1 trial), Austria (1 trial), Belgium (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.